Filing Details
- Accession Number:
- 0000899243-17-028577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-12 21:08:43
- Reporting Period:
- 2017-12-11
- Accepted Time:
- 2017-12-12 21:08:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1712467 | Michael Demurjian | C/O Tyme Technologies, Inc. 44 Wall Street - 12Th Floor New York NY 10005 | Chief Operating Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-11 | 1,900 | $3.73 | 26,678,536 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $3.75, inclusive. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
